Hemispheric, an Israeli technology startup, has announced the development of an artificial intelligence model designed to decode the electrical activity of the human brain. By utilizing a dataset comprised of EEG (electroencephalogram) readings from 100,000 people, the company claims its software can translate complex neural patterns into actionable data. The primary goal of this technology is to assist medical professionals in the diagnosis of neurological and psychological conditions, with a specific focus on post-traumatic stress disorder (PTSD).

While the company presents this as a significant advancement in neuro-technology, the project faces skepticism from the scientific community. Experts cited in reports emphasize that the technology is currently unproven and has not yet undergone the rigorous clinical validation required for widespread medical application. The transition from experimental AI modeling to a reliable diagnostic tool involves significant hurdles, including the need for peer-reviewed clinical trials and regulatory approval. As it stands, the startup's claims regarding the 'language' of the brain are viewed by industry observers as a preliminary development rather than a ready-to-use medical solution.